L
Luru Dai
Researcher at Chinese Academy of Sciences
Publications - 54
Citations - 3822
Luru Dai is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Mesoporous silica & DNA origami. The author has an hindex of 26, co-authored 52 publications receiving 2955 citations. Previous affiliations of Luru Dai include Center of Advanced European Studies and Research & Forschungszentrum Jülich.
Papers
More filters
Journal ArticleDOI
DNA Origami as an In Vivo Drug Delivery Vehicle for Cancer Therapy
Qian Zhang,Qiao Jiang,Na Li,Luru Dai,Qing Liu,Linlin Song,Jinye Wang,Yaqian Li,Jie Tian,Jie Tian,Baoquan Ding,Yang Du +11 more
TL;DR: It is demonstrated that DNA origami possessed enhanced tumor passive targeting and long-lasting properties at the tumor region and exhibited remarkable antitumor efficacy without observable systemic toxicity in nude mice bearing orthotopic breast tumors labeled with green fluorescent protein.
Journal ArticleDOI
Near Infrared Light-Powered Janus Mesoporous Silica Nanoparticle Motors.
TL;DR: NIR-powered nanomotors with diameters of 50, 80, and 120 nm demonstrate a novel strategy for overcoming the necessity of chemical fuels and exhibit a significant improvement in the maneuverability of nanomutors while providing potential cargo transportation in a biofriendly manner.
Journal ArticleDOI
Macrophage Cell Membrane Camouflaged Au Nanoshells for in Vivo Prolonged Circulation Life and Enhanced Cancer Photothermal Therapy
TL;DR: Macrophage cell membrane-camouflaged gold nanoshells (AuNS) that can serve as a new generation of photothermal conversion agents for in vivo photothermal cancer therapy are presented and significantly enhance in vivo blood circulation time and local accumulation at the tumor when administered systematically.
Journal ArticleDOI
Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy
TL;DR: Engineering natural macrophage cell membrane-camouflaged mesoporous silica nanocapsules can reduce the arrested percentage of immune cells and tissues, effectively prolong the survival time of nanoparticles in blood circulation system, and improve the accumulation in tumor.
Journal ArticleDOI
Magnetic Mesoporous Silica Nanoparticles Cloaked by Red Blood Cell Membranes: Applications in Cancer Therapy
TL;DR: In’vivo experiments demonstrate that RBC@MMSNs can avoid immune clearance and achieve magnetic field (MF)-induced high accumulation in a tumor, which provides an innovative strategy for cancer therapy.